Cargando…
Beta-glucan contamination of pharmaceutical products: How much should we accept?
Beta-glucans are large polysaccharides produced by a range of prokaryotic and eukaryotic organisms. They have potential immunostimulatory properties and have been used with therapeutic intent as anti-microbial and anti-tumour agents. A range of other potentially beneficial effects have been describe...
Autores principales: | Barton, Claire, Vigor, Kim, Scott, Robert, Jones, Paul, Lentfer, Heike, Bax, Heather J., Josephs, Debra H., Karagiannis, Sophia N., Spicer, James F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069311/ https://www.ncbi.nlm.nih.gov/pubmed/27473075 http://dx.doi.org/10.1007/s00262-016-1875-9 |
Ejemplares similares
-
Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016) -
Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
por: Neun, Barry W., et al.
Publicado: (2020) -
Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022) -
IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020) -
How much should you worry about contaminant neutrons in spatially fractionated grid radiation therapy?
por: Mahmoudi, Farshid, et al.
Publicado: (2023)